![Foto de Fernando Jesús](/img/uploaded/21D5F6EB0AFCB7F744F359D6566A26DE.jpg)
Fernando Jesús
Antoñanzas Villar
CATEDRÁTICO DE UNIVERSIDAD
Argitalpenak (335) Fernando Jesús Antoñanzas Villar argitalpenak
2024
-
Cost-Effectiveness Analysis of Vaccines for COVID-19 According to Sex, Comorbidity and Socioeconomic Status: A Population Study
PharmacoEconomics, Vol. 42, Núm. 2, pp. 219-229
-
Randomised multicentre effectiveness trial of rapid syndromic testing by panel assay in children presenting to European emergency departments with acute respiratory infections-trial protocol for the ADEQUATE Paediatric trial
BMJ Open, Vol. 14, Núm. 4
2023
-
Cost of lost productivity from acute respiratory infections in South America
Revista Panamericana de Salud Publica/Pan American Journal of Public Health, Vol. 47
-
Does diagnostic testing always decrease antibiotics prescriptions?
European Journal of Health Economics, Vol. 24, Núm. 5, pp. 673-678
-
Tenders for generics and biosimilars: a challenging purchasing policy
European Journal of Health Economics
-
The impact of conventional cost-effectiveness analysis on pricing dynamics in the market of new medicines: a proposed countervailing approach
Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 23, Núm. 4, pp. 431-438
2022
-
Burden of disease attributed to acute respiratory infections in South America
Journal of Infection in Developing Countries, Vol. 16, Núm. 10, pp. 1614-1622
-
Diagnostic testing for sepsis: A systematic review of economic evaluations
Antibiotics, Vol. 11, Núm. 1
-
Seeking efficiency gains outside drugs and diagnostics
European Journal of Health Economics
2021
-
A multi-stakeholder multicriteria decision analysis for the reimbursement of orphan drugs (FinMHU-MCDA study)
Orphanet Journal of Rare Diseases, Vol. 16, Núm. 1
-
Analysis of the prescription of antibiotics during the implementation of COVID-19 personal protection measures in a regional health system
ClinicoEconomics and Outcomes Research, Vol. 13, pp. 927-936
-
Drug prices in Latin American countries: the case of rheumatoid arthritis Biosimilars
Advances in Rheumatology, Vol. 61, Núm. 1
-
Economic Analyses of Respiratory Tract Infection Diagnostics: A Systematic Review
PharmacoEconomics, Vol. 39, Núm. 12, pp. 1411-1427
-
Efficiency of diagnostic testing for helicobacter pylori infections—a systematic review
Antibiotics, Vol. 10, Núm. 1, pp. 1-11
-
Health-Economic Analyses of Diagnostics: Guidance on Design and Reporting
PharmacoEconomics, Vol. 39, Núm. 12, pp. 1355-1363
-
Hispa-NICE: A Pipe Dream or a Realistic and Necessary Initiative?
PharmacoEconomics
-
Using point-of-care diagnostic testing for improved antibiotic prescription: an economic model
Health Economics Review, Vol. 11, Núm. 1
2020
-
Assessment of the quality of antibiotics prescription in a regional health system
Revista Clínica Española
-
Availability of biological cancer drugs under research: Registration and price in Brazil, Colombia, and Mexico
Physis, Vol. 30, Núm. 4, pp. 1-22
-
Effects of economic and health policies on the consumption of antibiotics in a Spanish region
Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 20, Núm. 4, pp. 379-386